Dianthus Therapeutics, Inc.DNTHNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 6↑334.8% | 3↓56.0% | 6↑120.6% |
| Gross Profit | -2 | 1↑174.6% | 6↑334.8% | 3↓56.0% | 6↑120.6% |
| Operating Income | -79 | -13↑83.4% | -30↓127.0% | -48↓62.2% | -102↓111.5% |
| Net Income | -75 | -13↑82.5% | -28↓117.2% | -44↓53.0% | -85↓95.1% |
| EBITDA | -73 | -13↑82.1% | -30↓125.9% | -48↓61.8% | -101↓112.2% |
| EPS Diluted | -27.30 | -3.82↑86.0% | -7.60↓99.0% | -8.45↓11.2% | -2.55↑69.8% |